Avant Diagnostics, Inc Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2018-06-13: Federal exemption Rule 506(b); Types of securities offered Equity; Series A Preferred Stock. The minimum amount disclosed in Item 11 may be modified by the Issuer in its sole discretion.; Date of first sale 2018-05-25; Total offering amount $2,000,000.
- 2016-01-20: Federal exemption Rule 506(b); Types of securities offered Convertible Promissory Note; Date of first sale 2016-01-05; Total offering amount $112,500.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2018-06-13 | Rule 506(b) | Equity; Series A Preferred Stock. The minimum amount disclosed in Item 11 may be modified by the Issuer in its sole discretion. | 2018-05-25 | $2,000,000 | $1,165,155 | $834,845 | 8 |
| 2016-01-20 | Rule 506(b) | Convertible Promissory Note | 2016-01-05 | $112,500 | $112,500 | $0 | 1 |